BIOMAT Database Logo BIOMAT Database Logo

Treatment of severe postgastrectomy dumping with a long-acting somatostatin analog: is effective management finally available? 1991

T A Miller

UI MeSH Term Description Entries
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004377 Dumping Syndrome Gastrointestinal symptoms resulting from an absent or nonfunctioning pylorus. Dumping Syndromes,Syndrome, Dumping,Syndromes, Dumping
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D015282 Octreotide A potent, long-acting synthetic SOMATOSTATIN octapeptide analog that inhibits secretion of GROWTH HORMONE and is used to treat hormone-secreting tumors; DIABETES MELLITUS; HYPOTENSION, ORTHOSTATIC; HYPERINSULINISM; hypergastrinemia; and small bowel fistula. Octreotide Acetate,Compound 201-995,Octreotide Acetate Salt,SAN 201-995,SM 201-995,SMS 201-995,Sandostatin,Sandostatine,Sandoz 201-995,Compound 201 995,Compound 201995,SAN 201 995,SAN 201995,SM 201 995,SM 201995,SMS 201 995,SMS 201995,Sandoz 201 995,Sandoz 201995

Related Publications

T A Miller
Octreotide, a long-acting somatostatin analog, in the management of postoperative dumping syndrome. An update.
February 1993, Digestive diseases and sciences,
T A Miller
Depot long-acting somatostatin analog (Sandostatin-LAR) is an effective treatment for acromegaly.
November 1995, The Journal of clinical endocrinology and metabolism,
T A Miller
[Treatment of carcinoid tumor with a long-acting somatostatin analog].
February 1993, Orvosi hetilap,
T A Miller
[Treatment of acromegaly with a long-acting synthetic analog of somatostatin].
January 1988, Archivos de investigacion medica,
T A Miller
Octreotide: a long-acting somatostatin analog.
October 1990, The American journal of the medical sciences,
T A Miller
Treatment of streptozotocin-diabetic dogs with a long-acting somatostatin analog.
May 1979, Diabetes,
T A Miller
Long acting somatostatin analogue in dumping syndrome.
December 1989, The British journal of surgery,
T A Miller
Long-term treatment of refractory neonatal hypoglycemia with long-acting somatostatin analog.
October 1987, The Journal of pediatrics,
T A Miller
Treatment of acromegaly with the long-acting somatostatin analog SMS 201-995.
January 1988, The Journal of clinical endocrinology and metabolism,
T A Miller
Successful treatment of ectopic Cushing's syndrome with the long-acting somatostatin analog octreotide.
January 1993, Experimental and clinical endocrinology,
Copied contents to your clipboard!